About: itos_admin

July 5th, 2017 “This is the future of cancer diagnosis, of cancer treatment, of cancer management, of cancer prognosis,” molecular medicine and genetics researcher Raj Atikkuke said Wednesday, surrounded by local oncologists and other researchers as he launched the company ITOS Oncology at Hotel-Dieu Grace. ITOS is a biomedical company which is rolling out cutting-edge…

In collaboration with the members of the Windsor Cancer Research Group (WCRG), ITOS is leading a multidisciplinary research study using blade cancer patient samples to identify a genetic signature that would predict the progression of cancer in these patients. ITOS is working on leading a clinical trial based on genomic profiling of myeloid malignancies from…